PROSTATE CANCER Challenges in selecting the optimal therapy

被引：2
|
作者：
Zelefsky, Michael J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
来源：
NATURE REVIEWS UROLOGY | 2012年 / 9卷 / 12期
关键词：
D O I：
10.1038/nrurol.2012.193
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The plethora of treatment options available for localized prostate cancer can make the patient's decision regarding which therapy to undergo a difficult one. A recent study has investigated the effect of using a decision aid to provide patients with enough information to make an informed decision about their therapy.
引用
收藏
页码：674 / 676
页数：4
相关论文
共 50 条
  • [21] Opportunities and Challenges in Targeting Ubiquitin Modification and Degradation for Prostate Cancer Therapy
    Peng, Yun-Hua
    Liu, Sha
    Cui, Li
    Liu, Jian-Kang
    Long, Jian-Gang
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (04) : 782 - 794
  • [22] PROSTATE CANCER UNITS FOR THE OPTIMAL MANAGEMENT OF PROSTATE CANCER
    Sciarra, Alessandro
    Salciccia, Stefano
    Minisola, Francesco
    Gentilucci, Alessandro
    Alfarone, Andrea
    Cattarino, Susanna
    Innocenzi, Michele
    Ravaziol, Michele
    Gentile, Vincenzo
    [J]. ANTICANCER RESEARCH, 2012, 32 (05) : 1863 - 1864
  • [23] Combined androgen blockade: an optimal therapy for minimally advanced prostate cancer?
    Soloway, MS
    [J]. BRITISH JOURNAL OF UROLOGY, 1998, 81 (01): : 87 - 94
  • [24] How to select the optimal therapy for early-stage prostate cancer
    Kollmeier, Marisa A.
    Zelefsky, Michael J.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) : 225 - 234
  • [25] Optimal systemic therapy in men with low-volume prostate cancer
    Saxena, Akshat
    Andrews, Jack
    Bryce, Alan Haruo
    Riaz, Irbaz Bin
    [J]. CURRENT OPINION IN UROLOGY, 2024, 34 (03) : 183 - 197
  • [26] Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer
    Abouharb, Sausan
    Corn, Paul G.
    [J]. CURRENT ONCOLOGY REPORTS, 2013, 15 (03) : 217 - 223
  • [27] How to select the optimal therapy for early-stage prostate cancer
    Kollmeier, Marisa A.
    Zelefsky, Michael J.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E6 - E15
  • [28] Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer
    Sausan Abouharb
    Paul G. Corn
    [J]. Current Oncology Reports, 2013, 15 : 217 - 223
  • [29] ENDOCRINE THERAPY OF PROSTATE-CANCER - OPTIMAL FORM AND APPROPRIATE TIMING
    CRAWFORD, ED
    DEANTONIO, EP
    LABRIE, F
    SCHRODER, FH
    GELLER, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04): : 1062 - 1066
  • [30] Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy
    Onik, Gary
    Barzell, Winston
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) : 506 - 510
12345